Dry Eye Disease — A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
Citation(s)
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)